IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 242 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $40,574 | -45.9% | 5,059 | 0.0% | 0.00% | -50.0% |
Q1 2024 | $74,975 | +82.3% | 5,059 | 0.0% | 0.01% | +50.0% |
Q4 2023 | $41,130 | +2272.0% | 5,059 | +1227.8% | 0.00% | – |
Q3 2023 | $1,734 | -86.4% | 381 | -79.0% | 0.00% | -100.0% |
Q2 2023 | $12,771 | +24.1% | 1,814 | +7.7% | 0.00% | 0.0% |
Q1 2023 | $10,290 | -4.4% | 1,684 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $10,761 | +976.1% | 1,684 | +1175.8% | 0.00% | – |
Q3 2022 | $1,000 | -66.7% | 132 | -49.0% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 259 | -7.8% | 0.00% | – |
Q1 2022 | $4,000 | -78.9% | 281 | -72.4% | 0.00% | -100.0% |
Q4 2021 | $19,000 | 0.0% | 1,017 | +31.6% | 0.00% | -33.3% |
Q3 2021 | $19,000 | +216.7% | 773 | +239.0% | 0.00% | +200.0% |
Q2 2021 | $6,000 | +200.0% | 228 | +240.3% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 67 | +3.1% | 0.00% | -100.0% |
Q4 2020 | $3,000 | +200.0% | 65 | +91.2% | 0.00% | – |
Q3 2020 | $1,000 | -75.0% | 34 | -77.3% | 0.00% | -100.0% |
Q1 2020 | $4,000 | – | 150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |